应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ESAIY Eisai Co., Ltd.
盘前交易 11-14 16:00:00 EST 延时
资讯
新帖
简况
美国OTC市场Eisai Co Ltd盘中异动 快速上涨5.06%
市场透视 · 00:16
美国OTC市场Eisai Co Ltd盘中异动 快速上涨5.06%
卫材(ESAIY)与礼来(LLY)就阿尔茨海默症的服药时间产生分歧
金吾财讯 · 07-31
卫材(ESAIY)与礼来(LLY)就阿尔茨海默症的服药时间产生分歧
【渤健(BIIB.US)盘前跌超5% 旗下阿尔茨海默症药物被欧洲监管机构否决】智通财经APP获悉,欧洲药品管理局(European Medicines Agency)的人类药品委员会拒绝了日本卫材(ESAIY.
智通财经 · 07-26
【渤健(BIIB.US)盘前跌超5% 旗下阿尔茨海默症药物被欧洲监管机构否决】智通财经APP获悉,欧洲药品管理局(European Medicines Agency)的人类药品委员会拒绝了日本卫材(ESAIY.
加载更多
公司概况
公司名称:
Eisai Co., Ltd.
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"ESAIY","market":"US","secType":"STK","nameCN":"Eisai Co., Ltd.","latestPrice":8.55,"timestamp":1731618000000,"preClose":8.11,"halted":0,"volume":815319,"delay":15,"floatShares":1076747898,"shares":1137465824,"eps":0.176978,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.44,"latestTime":"11-14 16:00:00 EST 延时","open":8.1,"high":9.27,"low":7.939,"amount":6988881.039200001,"amplitude":0.164118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.176978,"exchange":"PINK LIMITED","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731681000000},"adr":0,"adjPreClose":8.55,"adrRate":0.25,"volumeRatio":1.956299218688825},"requestUrl":"/m/hq/s/ESAIY","defaultTab":"news","newsList":[{"id":"2483338653","title":"美国OTC市场Eisai Co Ltd盘中异动 快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483338653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483338653?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:16","pubTimestamp":1731601002,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时16分,美国OTC市场Eisai Co Ltd股票出现异动,股价大幅拉升5.06%。截至发稿,该股报8.52美元/股,成交量4.1723万股,换手率0.00%,振幅7.16%。美国OTC市场Eisai Co Ltd股票所在的制药行业中,整体跌幅为0.57%。美国OTC市场Eisai Co Ltd公司简介:卫材有限公司是一家专业和仿制药制造公司。该公司绝大部分收入来自日本制药业务,其次是美洲制药业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500164298e42b19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500164298e42b19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ESAIY"],"gpt_icon":0},{"id":"2455316681","title":"卫材(ESAIY)与礼来(LLY)就阿尔茨海默症的服药时间产生分歧","url":"https://stock-news.laohu8.com/highlight/detail?id=2455316681","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455316681?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:27","pubTimestamp":1722432471,"startTime":"0","endTime":"0","summary":"据悉,卫材与渤健合作开发的Leqembi是首个减缓阿尔茨海默病进展的药物。此外,礼来的阿尔茨海默症治疗药物Kisunla本月早些时候在美国获得批准。礼来高管在周二的会议上强调,临床试验结果显示,在停止服用该药物的患者中,淀粉样斑块的重新形成非常缓慢。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/MjAwNTQ3MTMzNWUxMDE3ODY5MDY1MzA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MjAwNTQ3MTMzNWUxMDE3ODY5MDY1MzA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"278421","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU0823416689.USD","IE00B2B36J28.USD","LU0640476718.USD","LU0882574139.USD","LU1057294990.SGD","GB00BDT5M118.USD","BK4585","ESAIY","LU1623119135.USD","IE00BK4W5M84.HKD","LU0820561909.HKD","LU1267930730.SGD","IE0002141913.USD","LU1061106388.HKD","LU1064131342.USD","LU0289739699.SGD","LU0689472784.USD","LLY","LU0385154629.USD","IE00B4R5TH58.HKD","LU0820561818.USD","LU1069344957.HKD","IE00BFTCPJ56.SGD","LU0320765059.SGD","LU0079474960.USD","LU0096364046.USD","LU0114720955.EUR","LU0456855351.SGD","LU0097036916.USD","LU1712237335.SGD","LU0471298777.SGD","LU1804176565.USD","LU0256863902.USD","BK4516","IE0009355771.USD","LU0061475181.USD","LU0238689110.USD","LU0094547139.USD","BK4588","LU0466842654.USD","LU0943347566.SGD","LU1023059063.AUD","LU1551013425.SGD","LU0198837287.USD","IE00BK4W5L77.USD","LU0672654240.SGD","BK4007","BK4581","LU0417517546.SGD"],"gpt_icon":1},{"id":"2454344977","title":"【渤健(BIIB.US)盘前跌超5% 旗下阿尔茨海默症药物被欧洲监管机构否决】智通财经APP获悉,欧洲药品管理局(European Medicines Agency)的人类药品委员会拒绝了日本卫材(ESAIY.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454344977","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454344977?lang=zh_cn&edition=full","pubTime":"2024-07-26 20:57","pubTimestamp":1721998649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","IE00B19Z9Z06.USD","BK4139","ESAIY","IE00B19Z9P08.USD","BK4007","LU0109394709.USD","BIIB","BK4585","BK4588","LU0889565916.HKD","BK4533","IE00B894F039.SGD","LU0320765992.SGD","LU0234570918.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eisai.co.jp","exchange":"PINK LIMITED","name":"Eisai Co., Ltd.","nameEN":"Eisai Co., Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eisai Co., Ltd.(ESAIY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eisai Co., Ltd.(ESAIY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eisai Co., Ltd.,ESAIY,Eisai Co., Ltd.股票,Eisai Co., Ltd.股票老虎,Eisai Co., Ltd.股票老虎国际,Eisai Co., Ltd.行情,Eisai Co., Ltd.股票行情,Eisai Co., Ltd.股价,Eisai Co., Ltd.股市,Eisai Co., Ltd.股票价格,Eisai Co., Ltd.股票交易,Eisai Co., Ltd.股票购买,Eisai Co., Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eisai Co., Ltd.(ESAIY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eisai Co., Ltd.(ESAIY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}